Literature DB >> 2902384

Increase in myocardial Gi-proteins in heart failure.

J Neumann1, W Schmitz, H Scholz, L von Meyerinck, V Döring, P Kalmar.   

Abstract

The contractile response and myocardial content of Gi-proteins were examined in cardiac preparations from explanted hearts of four different patients with end-stage heart failure. Three patients had idiopathic dilated cardiomyopathy and one patient had inflammatory heart disease. Preparations from patients with idiopathic dilated cardiomyopathy showed reduced contractile response to the cAMP-increasing agent isoprenaline and an increase in myocardial Gi-proteins, compared with preparations from non-failing hearts. Therefore it is conceivable that an increase in myocardial Gi-proteins is causally related to heart failure due to idiopathic dilated cardiomyopathy. In the preparation from the patient with inflammatory heart disease the contractile response to isoprenaline was not reduced and likewise content of Gi-proteins was not changed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902384     DOI: 10.1016/s0140-6736(88)92601-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  65 in total

Review 1.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Functional properties of the rat phosphatase 1alpha promoter.

Authors:  B Linck; P Boknik; J Knapp; K Kikuchi; H Lüss; F U Müller; K Nomoto; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

Review 3.  Integration of pathways that signal cardiac growth with modulation of myofilament activity.

Authors:  R John Solaro; David M Montgomery; Lynn Wang; Eileen M Burkart; Yunbo Ke; Susan Vahebi; Peter Buttrick
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

Review 4.  Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability.

Authors:  Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-03       Impact factor: 3.000

5.  G-proteins (Gi, Go) in the basal ganglia of control and schizophrenic brain.

Authors:  F Okada; T J Crow; G W Roberts
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 6.  Mutations of signal-transducing G proteins in human disease.

Authors:  P Schnabel; M Böhm
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

7.  Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts.

Authors:  S Bartel; B Stein; T Eschenhagen; U Mende; J Neumann; W Schmitz; E G Krause; P Karczewski; H Scholz
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 8.  Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure.

Authors:  W Schmitz; P Boknik; B Linck; F U Müller
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

9.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.

Authors:  Susanne Lutz; Roman A Mura; Hans Joerg Hippe; Christiane Tiefenbacher; Feraydoon Niroomand
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.